Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study

BACKGROUND: Inosine pranobex (Isoprinosine®) is an immunomodulatory drug approved in several countries for the treatment of viral infections. This study compared the efficacy and safety of inosine pranobex versus placebo in subjects with clinically diagnosed influenza-like illness, including subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Beran, Jiří, Šalapová, Eva, Špajdel, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100179/
https://www.ncbi.nlm.nih.gov/pubmed/27821093
http://dx.doi.org/10.1186/s12879-016-1965-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100179/
https://www.ncbi.nlm.nih.gov/pubmed/27821093
http://dx.doi.org/10.1186/s12879-016-1965-5

Ejemplares similares